Table 2 Relation between ABCG2 expression and clinical features of the patients
From: High expression of ABCG2 is associated with chemotherapy resistance of osteosarcoma
ABCG2 expression | p | ||
|---|---|---|---|
Normal expression (n = 25) | High expression (n = 43) | ||
Age (years) | |||
> 20 | 13 | 21 | 0.65 |
≤ 20 | 12 | 22 | |
Mean ± S.D. | 34.5 ± 15.7 | 35.6 ± 14.9 | 0.77 |
Gender | |||
Male | 11 | 19 | 0.98 |
Female | 14 | 24 | |
Enneking stages | |||
I | 4 | 9 | 0.35 |
IIA | 7 | 10 | |
IIB | 12 | 15 | |
III | 2 | 9 | |
Tumor size (cm) | 3.9 ± 1.5 | 6.1 ± 2.7 | < 0.01 |
Overall survival (month) | 38.9 ± 15.6 | 28.4 ± 14.4 | < 0.01 |